4.8 Article

Dual imaging-guided photothermal/photodynamic therapy using micelles

Journal

BIOMATERIALS
Volume 35, Issue 16, Pages 4656-4666

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2014.02.018

Keywords

Micelles; Photosensitizer; Near infrared fluorescent imaging; Photoacoustic imaging; Photothermal therapy; Photodynamic therapy

Funding

  1. National Natural Science Foundation of China [81202472, 81101101, 51273165, 81371596]
  2. National Basic Research Program [2012CB932500, 2013CB733802, 2014CB744503]
  3. Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
  4. Program for New Century Excellent Talents in University [NCET-13-0502]
  5. Fundamental Research Funds for the Central Universities [2013121039]

Ask authors/readers for more resources

We report a type of photosensitizer (PS)-loaded micelles integrating cyanine dye as potential theranostic micelles for precise anatomical tumor localization via dual photoacoustic (PA)/near-infrared fluorescent (NIRF) imaging modalities, and simultaneously superior cancer therapy via sequential synergistic photothermal therapy (PTT)/photodynamic therapy (PDT). The micelles exhibit enhanced photostability, cell internalization and tumor accumulation. The dual NIRF/PA imaging modalities of the micelles cause the high imaging contrast and spatial resolution of tumors, which provide precise anatomical localization of the tumor and its inner vasculature for guiding PTT/PDT treatments. Moreover, the micelles can generate severe photothermal damage on cancer cells and destabilization of the lysosomes upon PTT photo-irradiation, which subsequently facilitate synergistic photodynamic injury via PS under PDT treatment. The sequential treatments of PTT/PDT trigger the enhanced cytoplasmic delivery of PS, which contributes to the synergistic anticancer efficacy of PS. Our strategy provides a dual-modal cancer imaging with high imaging contrast and spatial resolution, and subsequent therapeutic synergy of PTT/PDT for potential multimodal theranostic application. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available